Search for: "Novartis International AG"
Results 21 - 40
of 120
Sorted by Relevance
|
Sort by Date
25 Jan 2023, 7:25 am
More from our authors: Vissers Annotated European Patent Convention 2022 Edition by Kaisa Suominen, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 The Digital Economy and International Trade: Transnational Data Flows… [read post]
22 Jun 2019, 9:15 am
The landmark judgment of the Supreme Court of India in Novartis AG & Ors. .v. [read post]
1 Jul 2020, 2:02 pm
Now we want to take a closer look at the Novartis internal review of Bevou vision-related side effect cases observed in the HAWK & HARRIER clinical trials, including rare post-marketing safety reports of vasculitis. [read post]
28 Apr 2013, 9:32 am
* * * The following allegations are based on the government’s complaint filed in the Southern District of New York: Novartis, a pharmaceutical company headquartered in East Hanover, N.J., is a subsidiary of Novartis AG, an international pharmaceutical company headquartered in Basel, Switzerland. [read post]
1 Oct 2010, 3:38 am
Court of Appeal (Civil Division) Novartis AG & Anor v Johnson & Johnson Medical Ltd & Anor [2010] EWCA Civ 1039 (29 September 2010) High Court (Administrative Court) MXL, R (on the application of) & Ors v Secretary of State for the Home Department [2010] EWHC 2397 (Admin) (30 September 2010) High Court (Chancery Division) Anfield (UK) Ltd v Bank of Scotland Plc & Ors [2010] EWHC 2374 (Ch) (24 September 2010) Shepherd v Williamson & Anor [2010] EWHC 2375… [read post]
27 Feb 2020, 12:40 pm
Beovu injections were approved by the FDA in October 2019 to treat wet age-related macular degeneration, a condition that can eventually lead to blindness. [read post]
26 Nov 2007, 3:06 pm
In June 2006 the Annals of Internal Medicine published the findings of a new analysis of 19 previous studies concerning Serevent, Advair, and Foradil. [read post]
4 Dec 2015, 2:55 am
Novartis AG & Novartis GmbH regarding the validity and (in)direct infringement of EP 0296 689, Novartis’ Swiss type 2nd medical use patent covering the use of zoledronate in the preparation of a medicament for the treatment of osteoporosis. [read post]
10 Feb 2013, 8:30 am
Novartis AG is also recalling about 185 lots of cough syrup. [read post]
25 Jun 2018, 3:49 am
Starting from 2009, when the Supreme Commercial Court restrained a generic drug for the first time (Novartis AG vs. [read post]
17 Jul 2020, 8:57 am
Geneva time (CET)Connect to the meeting via: https://washington.zoom.us/j/94575494401Participants: · Delia Ferreira Rubio, Chair, Transparency International · Klaus Moosmayer, Member of the Executive Committee Novartis, Chief Ethics, Risk and Compliance Officer, Novartis International… [read post]
20 Aug 2009, 1:06 pm
For example, in 2004, Teva filed and won a lawsuit against Novartis International AG. [read post]
23 Nov 2023, 1:42 am
Union Of India (Novartis DB), Manu/TN/1263/2007 and Supreme Court decision in Novartis AG[2]Novartis AG v. [read post]
21 Jun 2010, 8:45 am
About the Authors Philip Grubb is an Intellectual Property Consultant; formerly Intellectual Property Counsel, Novartis International AG; Adjunct professor, Franklin Pierce Law Center, Concord, NH. [read post]
19 Oct 2012, 6:13 pm
Assets related to four of the markets would be divested to Sandoz International GmbH, a subsidiary of Novartis AG. [read post]
25 Sep 2008, 10:06 am
Reflections on the Interpretation of Article 27 TRIPS from Novartis v. [read post]
22 Jul 2010, 8:35 am
Ian Bryan, IP Counsel, GE Healthcare Vineet Kohli, Senior Patent Attorney, Merck John Beatty, Patent Procedures Management, European Patent Office Dr Roman Maksymiw, Head of Division, German Patent and Trademark Office, DPMA Lawrence Cullen, Deputy Director, IPO Dr Scott Alban, Head of IP, MedImmune Allen Norris, Vice President, Head Group IP, UCB Pharma SA Peter Thomsen, Manager Global IP Litigation and Global Policy, Novartis International AG … [read post]
27 Jan 2021, 11:07 am
Badboy pharmaceutical giant Novartis AG and two of its subsidiaries paid the DOJ and SEC $346.7 million. [read post]
6 Oct 2010, 4:22 am
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated protein from B… [read post]
31 Dec 2019, 3:58 am
In one case, Novartis AG, a Swiss pharmaceutical company, developed “Glivec”, an anti-cancer drug. [read post]
